SRTS
Sensus Healthcare Inc (SRTS)
Healthcare • NASDAQ • $3.08-26.58%
- Symbol
- SRTS
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $3.08
- Daily Change
- -26.58%
- Market Cap
- $50.70M
- Trailing P/E
- N/A
- Forward P/E
- 32.42
- 52W High
- $5.92
- 52W Low
- $2.82
- Analyst Target
- $6.25
- Dividend Yield
- N/A
- Beta
- 1.19
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry paramete…
Company websiteResearch SRTS on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.